Purchase Order 75N92E20P00001

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $15,314.69 on August 23, 2017, with an ultimate completion date of September 22, 2017. Work is performed in North Bethesda, Maryland. The order covers sequencing reagents and consumables under firm fixed price terms. No set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $13,250.00 on May 1, 2019, with a firm fixed price structure and ultimate completion date of July 26, 2020. Place of performance is Bethesda, Maryland. The order procures sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product portfolio in federal civilian research and diagnostic applications. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $17,735.76 on December 21, 2018, with completion by December 25, 2019. The order is a firm fixed price acquisition with no set-aside. Work is performed at Bethesda, Maryland. The purchase order procures DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product lines serving federal health and research agencies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $22,572.40 on August 18, 2017, with ultimate completion on September 17, 2017. The order is firm fixed price with no set-aside. Performance takes place in North Bethesda, Maryland. The procurement covers sequencing reagents, consumables, or related biotechnology products consistent with Illumina's core offerings to NIH institutes.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $10,517.76 on March 28, 2019, with completion due April 26, 2019. Place of performance is San Diego, California. The order is firm fixed price with no set-aside category. Specific procurement details regarding the items or services ordered are not provided in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $15,314.69 on July 31, 2018, with final completion by August 29, 2018. The order is firm fixed price with no set-aside. Performance occurs in Bethesda, Maryland. The purchase order procures sequencing reagents, consumables, or related bioinformatics products from Illumina's core portfolio of DNA and RNA sequencing supplies and software.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $8,182.85 on August 15, 2017, with ultimate completion on September 14, 2017. Place of performance is Bethesda, Maryland. The order procures sequencing reagents, consumables, or related products under firm fixed price terms. No set-aside was applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $17,675.00 on September 3, 2019, with ultimate completion on September 3, 2020. No set-aside was used. Work is performed in San Diego, California. The order is firm fixed price.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $16,285.00 on August 15, 2017, with a completion date of December 1, 2017. No set-aside was used. Place of performance is Bethesda, Maryland. The order covers sequencing reagents, consumables, or related bioinformatics supplies, consistent with Illumina's core product line of DNA and RNA sequencing instruments and materials. Pricing is firm fixed price.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $21,912.66 on August 2, 2017, with performance completion by September 1, 2017. Work is performed in Bethesda, Maryland. The order procures sequencing reagents, consumables, or related bioinformatics materials—Illumina's core product offerings to federal research agencies. No set-aside category applies.</p>